Yesterday, our Chief Executive, Michelle Riddalls, gave evidence to the House of Lords European Affairs Sub-Committee on the Protocol on Ireland/Northern Ireland for its follow-up inquiry into the Windsor Framework.
Michelle outlined how PAGB and our members were encouraged by how the UK Government and the European Union took steps to address the serious challenges for medicines posed by the Northern Ireland Protocol in the Windsor Framework. Michelle reiterated our members’ concerns around the submission requirements to the MHRA, the implementation timings and potential supply issues.
